Long-Term  ||| S:0 E:10 ||| JJ
Effects  ||| S:10 E:18 ||| NNPS
of  ||| S:18 E:21 ||| IN
Renal  ||| S:21 E:27 ||| NNP
Sympathetic  ||| S:27 E:39 ||| NNP
Denervation  ||| S:39 E:51 ||| NNP
on  ||| S:51 E:54 ||| IN
Hypertensive  ||| S:54 E:67 ||| NNP
Patients  ||| S:67 E:76 ||| NNPS
With  ||| S:76 E:81 ||| IN
Mild  ||| S:81 E:86 ||| NNP
to  ||| S:86 E:89 ||| TO
Moderate  ||| S:89 E:98 ||| NNP
Chronic  ||| S:98 E:106 ||| NNP
Kidney  ||| S:106 E:113 ||| NNP
Disease  ||| S:113 E:121 ||| NNP
Thirty  ||| S:121 E:128 ||| NNP
patients  ||| S:128 E:137 ||| NNS
who  ||| S:137 E:141 ||| WP
underwent  ||| S:141 E:151 ||| VBD
percutaneous  ||| S:151 E:164 ||| JJ
renal  ||| S:164 E:170 ||| JJ
denervation ||| S:170 E:181 ||| NN
,  ||| S:181 E:183 ||| ,
which  ||| S:183 E:189 ||| WDT
was  ||| S:189 E:193 ||| VBD
performed  ||| S:193 E:203 ||| VBN
by  ||| S:203 E:206 ||| IN
a  ||| S:206 E:208 ||| DT
single  ||| S:208 E:215 ||| JJ
operator  ||| S:215 E:224 ||| NN
following  ||| S:224 E:234 ||| VBG
the  ||| S:234 E:238 ||| DT
standard  ||| S:238 E:247 ||| JJ
technique ||| S:247 E:256 ||| NN
,  ||| S:256 E:258 ||| ,
were  ||| S:258 E:263 ||| VBD
enrolled  ||| S:263 E:272 ||| VBN
in  ||| S:272 E:275 ||| IN
this  ||| S:275 E:280 ||| DT
study ||| S:280 E:285 ||| NN
.  ||| S:285 E:287 ||| .
Patients  ||| S:287 E:296 ||| NNS
with  ||| S:296 E:301 ||| IN
chronic  ||| S:301 E:309 ||| JJ
kidney  ||| S:309 E:316 ||| NN
disease  ||| S:316 E:324 ||| NN
( ||| S:324 E:325 ||| -LRB-
CKD ||| S:325 E:328 ||| NNP
)  ||| S:328 E:330 ||| -RRB-
stage  ||| S:330 E:336 ||| NN
2  ||| S:336 E:338 ||| CD
( ||| S:338 E:339 ||| -LRB-
n=19 ||| S:339 E:343 ||| NNP
) ||| S:343 E:344 ||| -RRB-
,  ||| S:344 E:346 ||| ,
3  ||| S:346 E:348 ||| CD
( ||| S:348 E:349 ||| -LRB-
n=6 ||| S:349 E:352 ||| NNP
) ||| S:352 E:353 ||| -RRB-
,  ||| S:353 E:355 ||| ,
and  ||| S:355 E:359 ||| CC
4  ||| S:359 E:361 ||| CD
( ||| S:361 E:362 ||| -LRB-
n=5 ||| S:362 E:365 ||| NNP
)  ||| S:365 E:367 ||| -RRB-
were  ||| S:367 E:372 ||| VBD
included ||| S:372 E:380 ||| VBN
.  ||| S:380 E:382 ||| .
Data  ||| S:382 E:387 ||| NNP
were  ||| S:387 E:392 ||| VBD
obtained  ||| S:392 E:401 ||| VBN
at  ||| S:401 E:404 ||| IN
baseline  ||| S:404 E:413 ||| NN
and  ||| S:413 E:417 ||| CC
at  ||| S:417 E:420 ||| IN
monthly  ||| S:420 E:428 ||| JJ
intervals  ||| S:428 E:438 ||| NNS
for  ||| S:438 E:442 ||| IN
the  ||| S:442 E:446 ||| DT
first  ||| S:446 E:452 ||| JJ
6  ||| S:452 E:454 ||| CD
months ||| S:454 E:460 ||| NNS
.  ||| S:460 E:462 ||| .
At  ||| S:462 E:465 ||| IN
7  ||| S:465 E:467 ||| CD
months ||| S:467 E:473 ||| NNS
,  ||| S:473 E:475 ||| ,
follow-up  ||| S:475 E:485 ||| JJ
data  ||| S:485 E:490 ||| NNS
were  ||| S:490 E:495 ||| VBD
collected  ||| S:495 E:505 ||| VBN
bimonthly  ||| S:505 E:515 ||| VBN
until  ||| S:515 E:521 ||| IN
month  ||| S:521 E:527 ||| NN
12 ||| S:527 E:529 ||| CD
,  ||| S:529 E:531 ||| ,
after  ||| S:531 E:537 ||| IN
which  ||| S:537 E:543 ||| WDT
data  ||| S:543 E:548 ||| NNS
were  ||| S:548 E:553 ||| VBD
collected  ||| S:553 E:563 ||| VBN
on  ||| S:563 E:566 ||| IN
a  ||| S:566 E:568 ||| DT
quarterly  ||| S:568 E:578 ||| JJ
basis ||| S:578 E:583 ||| NN
.  ||| S:583 E:585 ||| .
Baseline  ||| S:585 E:594 ||| JJ
blood  ||| S:594 E:600 ||| NN
pressure  ||| S:600 E:609 ||| NN
values  ||| S:609 E:616 ||| NNS
( ||| S:616 E:617 ||| -LRB-
mean±standard  ||| S:617 E:631 ||| NNP
deviation ||| S:631 E:640 ||| NN
)  ||| S:640 E:642 ||| -RRB-
were  ||| S:642 E:647 ||| VBD
185±18 ||| S:647 E:653 ||| CD
/ ||| S:653 E:654 ||| CD
107±13  ||| S:654 E:661 ||| CD
mm  ||| S:661 E:664 ||| CD
Hg  ||| S:664 E:667 ||| NNS
in  ||| S:667 E:670 ||| IN
the  ||| S:670 E:674 ||| DT
office  ||| S:674 E:681 ||| NN
and  ||| S:681 E:685 ||| CC
152±17 ||| S:685 E:691 ||| CD
/ ||| S:691 E:692 ||| CD
93±11  ||| S:692 E:698 ||| CD
mm  ||| S:698 E:701 ||| CD
Hg  ||| S:701 E:704 ||| NNS
through  ||| S:704 E:712 ||| IN
24-hour  ||| S:712 E:720 ||| JJ
ambulatory  ||| S:720 E:731 ||| JJ
blood  ||| S:731 E:737 ||| NN
pressure  ||| S:737 E:746 ||| NN
monitoring  ||| S:746 E:757 ||| NN
( ||| S:757 E:758 ||| -LRB-
ABPM ||| S:758 E:762 ||| NNP
) ||| S:762 E:763 ||| -RRB-
.  ||| S:763 E:765 ||| .
Three  ||| S:765 E:771 ||| CD
patients  ||| S:771 E:780 ||| NNS
with  ||| S:780 E:785 ||| IN
stage  ||| S:785 E:791 ||| NN
4  ||| S:791 E:793 ||| CD
CKD  ||| S:793 E:797 ||| NNP
required  ||| S:797 E:806 ||| VBD
chronic  ||| S:806 E:814 ||| JJ
renal  ||| S:814 E:820 ||| JJ
replacement  ||| S:820 E:832 ||| NN
therapy  ||| S:832 E:840 ||| NN
( ||| S:840 E:841 ||| -LRB-
one  ||| S:841 E:845 ||| CD
at  ||| S:845 E:848 ||| IN
the  ||| S:848 E:852 ||| DT
13-month  ||| S:852 E:861 ||| NNP
follow-up  ||| S:861 E:871 ||| NNP
and  ||| S:871 E:875 ||| CC
two  ||| S:875 E:879 ||| CD
at  ||| S:879 E:882 ||| IN
the  ||| S:882 E:886 ||| DT
14-month  ||| S:886 E:895 ||| JJ
follow-up ||| S:895 E:904 ||| NN
)  ||| S:904 E:906 ||| -RRB-
after  ||| S:906 E:912 ||| IN
episodes  ||| S:912 E:921 ||| NNS
of  ||| S:921 E:924 ||| IN
acute  ||| S:924 E:930 ||| JJ
renal  ||| S:930 E:936 ||| JJ
injury ||| S:936 E:942 ||| NN
;  ||| S:942 E:944 ||| :
their  ||| S:944 E:950 ||| PRP$
follow-up  ||| S:950 E:960 ||| NN
was  ||| S:960 E:964 ||| VBD
subsequently  ||| S:964 E:977 ||| RB
discontinued ||| S:977 E:989 ||| VBN
.  ||| S:989 E:991 ||| .
The  ||| S:991 E:995 ||| DT
office  ||| S:995 E:1002 ||| NN
blood  ||| S:1002 E:1008 ||| NN
pressure  ||| S:1008 E:1017 ||| NN
values  ||| S:1017 E:1024 ||| NNS
at  ||| S:1024 E:1027 ||| IN
the  ||| S:1027 E:1031 ||| DT
24-month  ||| S:1031 E:1040 ||| JJ
follow-up  ||| S:1040 E:1050 ||| NN
were  ||| S:1050 E:1055 ||| VBD
131±15 ||| S:1055 E:1061 ||| FW
/ ||| S:1061 E:1062 ||| FW
87±9  ||| S:1062 E:1067 ||| FW
mm  ||| S:1067 E:1070 ||| FW
Hg  ||| S:1070 E:1073 ||| FW
( ||| S:1073 E:1074 ||| -LRB-
P  ||| S:1074 E:1075 ||| NNP
< ||| S:1075 E:1076 ||| SYM
.0001 ||| S:1076 E:1081 ||| NNP
,  ||| S:1081 E:1083 ||| ,
for  ||| S:1083 E:1087 ||| IN
both  ||| S:1087 E:1092 ||| DT
comparisons ||| S:1092 E:1103 ||| NNS
) ||| S:1103 E:1104 ||| -RRB-
;  ||| S:1104 E:1106 ||| :
the  ||| S:1106 E:1110 ||| DT
corresponding  ||| S:1110 E:1124 ||| JJ
ABPM  ||| S:1124 E:1129 ||| NN
values  ||| S:1129 E:1136 ||| NNS
were  ||| S:1136 E:1141 ||| VBD
132±14 ||| S:1141 E:1147 ||| FW
/ ||| S:1147 E:1148 ||| FW
84±12  ||| S:1148 E:1154 ||| FW
mm  ||| S:1154 E:1157 ||| FW
Hg  ||| S:1157 E:1160 ||| FW
( ||| S:1160 E:1161 ||| -LRB-
P  ||| S:1161 E:1162 ||| NNP
< ||| S:1162 E:1163 ||| SYM
.0001 ||| S:1163 E:1168 ||| NNP
,  ||| S:1168 E:1170 ||| ,
for  ||| S:1170 E:1174 ||| IN
both  ||| S:1174 E:1179 ||| DT
comparisons ||| S:1179 E:1190 ||| NNS
) ||| S:1190 E:1191 ||| -RRB-
.  ||| S:1191 E:1193 ||| .
The  ||| S:1193 E:1197 ||| DT
mean  ||| S:1197 E:1202 ||| VBP
estimated  ||| S:1202 E:1212 ||| VBN
glomerular  ||| S:1212 E:1223 ||| JJ
filtration  ||| S:1223 E:1234 ||| JJ
rate  ||| S:1234 E:1239 ||| NN
increased  ||| S:1239 E:1249 ||| VBN
from  ||| S:1249 E:1254 ||| IN
61.9±23.9  ||| S:1254 E:1264 ||| FW
mL ||| S:1264 E:1266 ||| FW
/ ||| S:1266 E:1267 ||| FW
min ||| S:1267 E:1270 ||| FW
/ ||| S:1270 E:1271 ||| FW
1.73  ||| S:1271 E:1276 ||| FW
m ||| S:1276 E:1277 ||| FW
( ||| S:1277 E:1278 ||| -LRB-
2 ||| S:1278 E:1279 ||| LS
)  ||| S:1279 E:1281 ||| -RRB-
to  ||| S:1281 E:1284 ||| TO
88.0±39.8  ||| S:1284 E:1294 ||| FW
mL ||| S:1294 E:1296 ||| FW
/ ||| S:1296 E:1297 ||| FW
min ||| S:1297 E:1300 ||| FW
/ ||| S:1300 E:1301 ||| FW
1.73  ||| S:1301 E:1306 ||| FW
m ||| S:1306 E:1307 ||| FW
( ||| S:1307 E:1308 ||| -LRB-
2 ||| S:1308 E:1309 ||| LS
)  ||| S:1309 E:1311 ||| -RRB-
( ||| S:1311 E:1312 ||| -LRB-
P  ||| S:1312 E:1313 ||| NNP
< ||| S:1313 E:1314 ||| SYM
.0001 ||| S:1314 E:1319 ||| NNP
) ||| S:1319 E:1320 ||| -RRB-
.  ||| S:1320 E:1322 ||| .
The  ||| S:1322 E:1326 ||| DT
urine  ||| S:1326 E:1332 ||| JJ
albumin ||| S:1332 E:1339 ||| NN
: ||| S:1339 E:1340 ||| :
creatinine  ||| S:1340 E:1351 ||| JJ
ratio  ||| S:1351 E:1357 ||| NN
decreased  ||| S:1357 E:1367 ||| VBD
from  ||| S:1367 E:1372 ||| IN
99.8  ||| S:1372 E:1377 ||| CD
mg ||| S:1377 E:1379 ||| CD
/ ||| S:1379 E:1380 ||| CD
g  ||| S:1380 E:1382 ||| NNS
( ||| S:1382 E:1383 ||| -LRB-
interquartile  ||| S:1383 E:1397 ||| JJ
range ||| S:1397 E:1402 ||| NN
,  ||| S:1402 E:1404 ||| ,
38.0-192.1 ||| S:1404 E:1414 ||| CD
)  ||| S:1414 E:1416 ||| -RRB-
to  ||| S:1416 E:1419 ||| TO
11.0  ||| S:1419 E:1424 ||| CD
mg ||| S:1424 E:1426 ||| CD
/ ||| S:1426 E:1427 ||| CD
g  ||| S:1427 E:1429 ||| NNS
( ||| S:1429 E:1430 ||| -LRB-
interquartile  ||| S:1430 E:1444 ||| JJ
range ||| S:1444 E:1449 ||| NN
,  ||| S:1449 E:1451 ||| ,
4.1-28.1 ||| S:1451 E:1459 ||| NNP
;  ||| S:1459 E:1461 ||| :
P  ||| S:1461 E:1462 ||| FW
< ||| S:1462 E:1463 ||| SYM
.0001  ||| S:1463 E:1469 ||| FW
mg ||| S:1469 E:1471 ||| FW
/ ||| S:1471 E:1472 ||| FW
g ||| S:1472 E:1473 ||| FW
) ||| S:1473 E:1474 ||| -RRB-
.  ||| S:1474 E:1476 ||| .
At  ||| S:1476 E:1479 ||| IN
the  ||| S:1479 E:1483 ||| DT
end  ||| S:1483 E:1487 ||| NN
of  ||| S:1487 E:1490 ||| IN
the  ||| S:1490 E:1494 ||| DT
follow-up  ||| S:1494 E:1504 ||| JJ
period ||| S:1504 E:1510 ||| NN
,  ||| S:1510 E:1512 ||| ,
21  ||| S:1512 E:1515 ||| CD
patients  ||| S:1515 E:1524 ||| NNS
( ||| S:1524 E:1525 ||| -LRB-
70 ||| S:1525 E:1527 ||| CD
%  ||| S:1527 E:1529 ||| NN
of  ||| S:1529 E:1532 ||| IN
the  ||| S:1532 E:1536 ||| DT
initial  ||| S:1536 E:1544 ||| JJ
sample ||| S:1544 E:1550 ||| NN
)  ||| S:1550 E:1552 ||| -RRB-
were  ||| S:1552 E:1557 ||| VBD
no  ||| S:1557 E:1560 ||| RB
longer  ||| S:1560 E:1567 ||| RB
classified  ||| S:1567 E:1578 ||| VBN
as  ||| S:1578 E:1581 ||| IN
having  ||| S:1581 E:1588 ||| VBG
CKD ||| S:1588 E:1591 ||| NNP
.  ||| S:1591 E:1593 ||| .
